Previous 10 | Next 10 |
New Omni 30° hysteroscope, Omni Lok cervical seal and Omni 5 French seal provide increased flexibility to support physicians both diagnosing and treating patients Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has launched its expanded Omni ® ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Hologic's continuous organic revenue growth bolstered investor's confidence in the company's future; Strength in Hologic's COVID-related product can be a catalyst in the company's international expansion strategy; Despite a solid financial performance, the company's stock underper...
Glenview Capital Management’s 13F portfolio value increased marginally from $5.90B to $5.96B this quarter. The number of positions increased from 63 to 64. They increased ViacomCBS and Global Payments while reducing Cigna, DXC Technology, Takeda Pharmaceuticals, and HCA Healthc...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
A new six-point plan, announced by President Joe Biden on Thursday to fight the pandemic requiring COVID-19 vaccinations or regular testing for nearly two-thirds of U.S. employees could overwhelm the manufacturers of COVID-19 tests, industry experts argue. While lab-based capacity is strong, ...
Coverage Further Validates Laparoscopic Radiofrequency Ablation for Women with Uterine Fibroids Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that Anthem Blue Cross Blue Shield, the second largest health plan in the United States, ha...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
The dream of truly being in a post-Covid-19 world is finally beginning to fade away with the rise of the Delta variant. The future appears more and more set on “management of an endemic pathogen” than the eradication of this foe. It will always find somewhere to hide out and mut...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. About XLV. A list of cheap stocks. For further details see: XLV: Healthcare Dashboard For August
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...